Home › Meningioma › Washington
Meningioma clinical trials in Washington
3 studies for Meningioma are looking for participants at sites in Washington.
Cities in Washington
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Valley Medical Center, Renton
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale
- North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT02523014Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Virginia Mason, Seattle
RecruitingObservational study
All ages · All sexes · Updated Jul 22, 2026 · NCT04427384Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- Fred Hutchinson Cancer Center, Seattle
RecruitingPhase 1/2
Ages 18 to 90 · All sexes · Updated May 14, 2026 · NCT05636618From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.